The 2nd HARMONY General Assembly is organised from 23-24 October 2017 at Bayer in Berlin. Bayer is one of the 51 HARMONY Alliance Partners.
At the General Assembly Alliance Partners and Associated Members meet to discuss topics that are important for all stakeholders and patients to get access to the right treatment at the right time, such as definition and alignment on outcomes.
Apart from presentations, parallel sessions are organised across the spectrum of hematologic malignancies: multiple myeloma (MM), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), non-Hodgkins lymphoma (NHL), myelodysplastic syndromes (MDS), and pediatric Hematologic Malignancies.
The General Assembly is a valuable annual meeting to attend for Alliance Partners and Associated Members, both from a substance as from a collaborative perspective.
Practical Information
@HARMONY Talks
During our two day event we will set up our studio and would like to invite you to talk about Big Data and Hematology! Share the HARMONY vision and/or share your experiences in the field on video; add your personal view on the challenges we face when addressing the unmet needs with HM patients. May we interview you as well? Let's talk and mail us to set the timeframe.
Are you interested in starting your research project while using big data analyses from HARMONY? Join our Alliance and become an Associate Member. Please contact the Coordination Office at harmonyoffice@ibsal.es.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
